Christopher Jones, MD
Transplant Surgery · Louisville, KYNPI 1598812315
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (37.1%), education and speaking fees — rather than concentrated in one kind of arrangement. Veloxis Pharmaceuticals, Inc. accounts for 79.9% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2020 at $13,664 and has fallen 95.8% since, to $579 in 2025.
Across 107 payments — averaging $314.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Veloxis Pharmaceuticals, Inc.$27K
- Intuitive Surgical$4K
- Stryker$1K
- Medtronic$230
- Novartis$219
- Paragonix Technologies, Inc.$170
- plus $1K from 13 others
Across 1 payment — averaging $12,027 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$12K
What the payments were for
- Consulting fees$12,50037%
- Speaking & faculty fees$4,74014%
- Travel & lodging$4,07412%
- Food & beverage$4,37713%
- Education$8,00024%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Veloxis Pharmaceuticals, Inc. | 38 | $26,925 |
| Intuitive Surgical | 7 | $3,811 |
| Stryker | 30 | $1,305 |
| Medtronic(2 entities) | 4 | $230 |
| Novartis | 2 | $219 |
| Paragonix Technologies, Inc. | 1 | $170 |
| Mallinckrodt Hospital Products Inc. | 2 | $140 |
| Pacira Pharmaceuticals Incorporated | 1 | $125 |
| AbbVie | 1 | $122 |
| AstraZeneca | 1 | $120 |
| Scpharmaceuticals Inc. | 1 | $119 |
| Davol Inc. | 1 | $103 |
| Ferring Pharmaceuticals Inc. | 6 | $79 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $61 |
| Amgen | 3 | $49 |
| Philips North America LLC | 2 | $42 |
| Biosense Webster, Inc. | 2 | $31 |
| Orthogenrx Inc. | 1 | $22 |
| Pfizer | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few transplant surgery providers in Kentuckyto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Valganciclovir Hcl | 25 | $8,931 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 46 | $268 |
| Prednisone | 39 | $110 |
| Ondansetron Hcl | 12 | $102 |
| Carvedilol | 11 | $80 |
| Amlodipine Besylate | 15 | $63 |
Paid to pharmacies, not to this prescriber.
Other transplant surgery in Louisville
- Eric DavisLouisville$78K
- Mary EngLouisville$6K
- Michael HughesLouisville$5K
- Yaser Al-SalmayLouisville$850
- Alejandro Cracco MahechaLexington$5K
- Malay ShahLexington$5K
- Meera GuptaLexington$3K
- Siddharth DesaiLexington$3K
- Alexandre AnchetaLexington$3K
- Matthew BlackLexington$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.